Lytix biopharma to present at the American society of…
Lytix Biopharma AS (Lytix), a clinical-stage company with an in situ vaccination technology!-->…
Lytix Biopharma AS (Lytix), a clinical-stage company with an in situ vaccination technology!-->…
Financial Results and Provide Business Update on May 9, 2022 BioLife Solutions, Inc. (NASDAQ:!-->!-->!-->…
Scopus BioPharma Inc. today announced the pricing of a $9 million follow-on public offering. The…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.